These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28409481)

  • 21. Dutch Tariff for the Five-Level Version of EQ-5D.
    M Versteegh M; M Vermeulen K; M A A Evers S; de Wit GA; Prenger R; A Stolk E
    Value Health; 2016 Jun; 19(4):343-52. PubMed ID: 27325326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis.
    Salaffi F; Carotti M; Ciapetti A; Gasparini S; Grassi W
    Clin Exp Rheumatol; 2011; 29(4):661-71. PubMed ID: 21813061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of contemporaneous responses for EQ-5D-3L and Minnesota Living with Heart Failure; a case for disease specific multiattribute utility instrument in cardiovascular conditions.
    Kularatna S; Byrnes J; Chan YK; Carrington MJ; Stewart S; Scuffham PA
    Int J Cardiol; 2017 Jan; 227():172-176. PubMed ID: 27865116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.
    Bernert S; Fernández A; Haro JM; König HH; Alonso J; Vilagut G; Sevilla-Dedieu C; de Graaf R; Matschinger H; Heider D; Angermeyer MC;
    Value Health; 2009; 12(5):750-8. PubMed ID: 19490564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting the EuroQol Group's EQ-5D index from CDC's "Healthy Days" in a US sample.
    Jia H; Zack MM; Moriarty DG; Fryback DG
    Med Decis Making; 2011; 31(1):174-85. PubMed ID: 20375418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-assessed health status in Poland: EQ-5D findings from the Polish valuation study.
    Golicki D; Niewada M; Jakubczyk M; Wrona W; Hermanowski T
    Pol Arch Med Wewn; 2010 Jul; 120(7-8):276-81. PubMed ID: 20693958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparing UK, USA and Australian values for EQ-5D as a health utility measure of oral health.
    Brennan DS; Teusner DN
    Community Dent Health; 2015 Sep; 32(3):180-4. PubMed ID: 26513855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire.
    König HH; Bernert S; Angermeyer MC; Matschinger H; Martinez M; Vilagut G; Haro JM; de Girolamo G; de Graaf R; Kovess V; Alonso J;
    Med Care; 2009 Feb; 47(2):255-61. PubMed ID: 19169128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of EQ-5D in Mexican city older population with and without dementia (SADEM study).
    Sanchez-Arenas R; Vargas-Alarcon G; Sanchez-Garcia S; Garcia-Peña C; Gutierrez-Gutierrez L; Grijalva I; Garcia-Dominguez A; Juárez-Cedillo T
    Int J Geriatr Psychiatry; 2014 May; 29(5):478-88. PubMed ID: 24123291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measuring health-related quality of life in bipolar disorder: relationship of the EuroQol (EQ-5D) to condition-specific measures.
    Hayhurst H; Palmer S; Abbott R; Johnson T; Scott J
    Qual Life Res; 2006 Sep; 15(7):1271-80. PubMed ID: 16972160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Which Questionnaire Should Be Used to Measure Quality-of-Life Utilities in Patients with Acute Leukemia? An Evaluation of the Validity and Interpretability of the EQ-5D-5L and Preference-Based Questionnaires Derived from the EORTC QLQ-C30.
    van Dongen-Leunis A; Redekop WK; Uyl-de Groot CA
    Value Health; 2016; 19(6):834-843. PubMed ID: 27712712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validity of the EuroQoL (EQ-5D) instrument in a Greek general population.
    Kontodimopoulos N; Pappa E; Niakas D; Yfantopoulos J; Dimitrakaki C; Tountas Y
    Value Health; 2008 Dec; 11(7):1162-9. PubMed ID: 18489492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing the EQ-5D and the SF-6D descriptive systems to assess their ceiling effects in the US general population.
    Bharmal M; Thomas J
    Value Health; 2006; 9(4):262-71. PubMed ID: 16903996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Italian population-based values of EQ-5D health states.
    Scalone L; Cortesi PA; Ciampichini R; Belisari A; D'Angiolella LS; Cesana G; Mantovani LG
    Value Health; 2013; 16(5):814-22. PubMed ID: 23947975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perceptions of the General Public About Health-related Quality of Life and the EQ-5D Questionnaire: A Qualitative Study in Korea.
    Ock M; Pyo J; Jo MW; Herdman M; Luo N
    J Prev Med Public Health; 2022 May; 55(3):213-225. PubMed ID: 35677995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of the development and testing of additional dimensions for the EQ-5D descriptive system.
    Kangwanrattanakul K; Phimarn W
    Expert Rev Pharmacoecon Outcomes Res; 2019 Aug; 19(4):431-443. PubMed ID: 31244348
    [No Abstract]   [Full Text] [Related]  

  • 38. Relationship among sociodemographic factors, clinical conditions, and health-related quality of life: examining the EQ-5D in the U.S. general population.
    Lubetkin EI; Jia H; Franks P; Gold MR
    Qual Life Res; 2005 Dec; 14(10):2187-96. PubMed ID: 16328899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the ICECAP-O with EQ-5D in a falls prevention clinical setting: are they complements or substitutes?
    Davis JC; Liu-Ambrose T; Richardson CG; Bryan S
    Qual Life Res; 2013 Jun; 22(5):969-77. PubMed ID: 22723152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Criteria for developing, assessing and selecting candidate EQ-5D bolt-ons.
    Mulhern BJ; Sampson C; Haywood P; Addo R; Page K; Mott D; Shah K; Janssen MF; Herdman M
    Qual Life Res; 2022 Oct; 31(10):3041-3048. PubMed ID: 35486216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.